A novel mRNA vaccine effectively triggered an antitumor immune response in a mouse model of pancreatic cancer, even completely eliminating the cancer in a…
News
September is Blood Cancer Awareness Month, and advocates around the world are joining together to shine a light on blood cancer and fundraise to…
Ionis Pharmaceuticals’ experimental injection therapy sapablursen may ease symptoms of polycythemia vera (PV) and reduce the need for blood draws to manage the…
A new CAR T-cell therapy designed to target multiple myeloma while sparing healthy immune cells has been given to its first patient in a…
PANCREATIC CANCER
FDA approves oral pancreatic cancer drug that extends survival
The U.S. Food and Drug Administration (FDA) has approved an oral drug for adults with pancreatic adenocarcinoma, the most common form of pancreatic cancer,…
Safusidenib, an experimental oral treatment for people with gliomas carrying IDH1 gene mutations, has received fast-track designation from…
Treating multiple myeloma with a Darzalex (daratumumab)-based combination may lead to a faster and longer-lasting response than a standard combination regimen using lenalidomide (sold…
Adding Moleculin Biotech’s experimental chemotherapy annamycin to the approved chemotherapy cytarabine may be more effective than cytarabine alone at controlling hard-to-treat acute myeloid leukemia…
Two clinical trials evaluating cemsidomide — an oral therapy candidate from C4 Therapeutics (C4T) that aims to limit cancer growth — in people with…
PANCREATIC CANCER
New pancreatic cancer therapy moves into Phase 2/3 clinical testing
Silexion Therapeutics has launched a Phase 2/3 clinical trial testing its experimental therapy SIL204 in combination with standard-of-care chemotherapy in people with pancreatic…
Recent Posts
- Newly approved injection therapy gives PV patients a new option
- Inventing words for caregiving experiences no else understands
- New add-on therapy may help delay worsening in hard-to-treat myeloma
- US trial testing new med in combo with approved drug for pancreatic cancer
- The power of hope against a new multiple myeloma diagnosis